<i>In vitro</i> antiviral activity of the anti-HCV drugs daclatasvir and sofosbuvir against SARS-CoV-2, the aetiological agent of COVID-19Carolina Q. Sacramento, Thiago Moreno L. Souza, Suelen da Silva Gomes Dias et al.|Journal of Antimicrobial Chemotherapy|2021Cited by 104
The <i>in vitro</i> antiviral activity of the anti-hepatitis C virus (HCV) drugs daclatasvir and sofosbuvir against SARS-CoV-2Carolina Q. Sacramento, Thiago Moreno L. Souza, Natalia Fintelman‐Rodrigues et al.|bioRxiv (Cold Spring Harbor Laboratory)|2020Cited by 37